Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
3.600
-0.100 (-2.70%)
At close: Apr 28, 2026, 4:00 PM EDT
3.420
-0.180 (-5.00%)
Pre-market: Apr 29, 2026, 7:28 AM EDT
Turn Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -3.19 | -1.77 | -2.29 | -4.29 |
| Depreciation & Amortization | 0.05 | 0.05 | 0.04 | 0.05 |
| Stock-Based Compensation | 0.67 | 0.35 | 0.64 | 1.88 |
| Other Operating Activities | -2.46 | 0.01 | 0 | 0.05 |
| Change in Accounts Payable | 2.26 | 0.2 | 0.21 | -0.3 |
| Change in Unearned Revenue | - | - | 0.02 | 1.42 |
| Change in Other Net Operating Assets | 0.11 | -0.2 | 0 | -0.01 |
| Operating Cash Flow | -2.56 | -1.36 | -1.38 | -1.21 |
| Sale (Purchase) of Intangibles | -0.15 | -0.1 | -0.04 | -0.02 |
| Investing Cash Flow | -0.15 | -0.1 | -0.04 | -0.02 |
| Issuance of Common Stock | 6.92 | 1.15 | 0.5 | 0.35 |
| Financing Cash Flow | 6.92 | 1.15 | 0.5 | 0.35 |
| Net Cash Flow | 4.2 | -0.31 | -0.92 | -0.87 |
| Levered Free Cash Flow | 1.74 | -0.82 | -2.01 | - |
| Unlevered Free Cash Flow | 1.74 | -0.82 | -2.01 | - |
| Change in Working Capital | 2.37 | -0 | 0.23 | 1.1 |
Source: S&P Capital IQ. Standard template.
Financial Sources.